Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 373.66 billion. The enterprise value is 366.72 billion.

Market Cap	373.66B
Enterprise Value	366.72B

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Nov 10, 2025

Share Statistics

Current Share Class	124.89M
Shares Outstanding	n/a
Shares Change (YoY)	-0.41%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	42.34%
Owned by Institutions (%)	20.55%
Float	41.84M

Valuation Ratios

The trailing PE ratio is 36.83 and the forward PE ratio is 31.12.

PE Ratio	36.83
Forward PE	31.12
PS Ratio	7.18
PB Ratio	8.66
P/TBV Ratio	8.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	36.15
EV / Sales	7.05
EV / EBITDA	26.35
EV / EBIT	29.30
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	0.18
Debt / FCF	n/a
Interest Coverage	63.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	26.98%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	5.40M
Profits Per Employee	1.05M
Employee Count	9,628
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Ajanta Pharma has paid 2.85 billion in taxes.

Income Tax	2.85B
Effective Tax Rate	21.95%

Stock Price Statistics

The stock price has increased by +16.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+16.81%
50-Day Moving Average	2,838.09
200-Day Moving Average	2,642.26
Relative Strength Index (RSI)	60.14
Average Volume (20 Days)	13,029

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 52.02 billion and earned 10.15 billion in profits. Earnings per share was 81.21.

Revenue	52.02B
Gross Profit	39.67B
Operating Income	12.52B
Pretax Income	13.00B
Net Income	10.15B
EBITDA	13.80B
EBIT	12.52B
Earnings Per Share (EPS)	81.21

Full Income Statement

Balance Sheet

The company has 9.40 billion in cash and 2.46 billion in debt, giving a net cash position of 6.94 billion.

Cash & Cash Equivalents	9.40B
Total Debt	2.46B
Net Cash	6.94B
Net Cash Per Share	n/a
Equity (Book Value)	43.15B
Book Value Per Share	345.45
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.27%, with operating and profit margins of 24.06% and 19.50%.

Gross Margin	76.27%
Operating Margin	24.06%
Pretax Margin	24.99%
Profit Margin	19.50%
EBITDA Margin	26.52%
EBIT Margin	24.06%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 0.93%.

Dividend Per Share	28.00
Dividend Yield	0.93%
Dividend Growth (YoY)	-48.15%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.41%
Shareholder Yield	1.34%
Earnings Yield	2.72%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2